Hip Reconstruction Devices Market Size Forecasted to Reach USD 17.29 Billion by 2035

According to Precedence Research, the global hip reconstruction devices market size was estimated at USD 9.30 billion in 2025 and is forecasted to reach around USD 17.29 billion by 2035, expanding at a CAGR of 6.40% from 2026 to 2035. This growth is fueled by advancements in surgical techniques, innovations in implant materials, and the increasing demand for joint replacement surgeries.

Hip reconstruction devices, including implants for hip arthroplasty and hip resurfacing, are designed to restore mobility and alleviate pain caused by arthritis and other joint-related conditions. As the global population ages and the incidence of hip-related injuries rises, the demand for joint replacements and associated devices continues to increase.

Surgeons and medical device manufacturers are also innovating constantly, introducing new materials and technologies, which help improve patient outcomes and reduce recovery time.

Where Data Meets Strategic Clarity 📥 View Sample Pages of the Complete Report 👉 https://www.precedenceresearch.com/sample/8331

Hip Reconstruction Devices Market Size and Forecasts:

• Market size in 2025: USD 9.30 Billion
• Market size in 2026: USD 9.90 Billion
• Market size by 2035: USD 17.29 Billion
• CAGR: 6.40% (2026-2035)
• Forecast period: 2026-2035
• Base year: 2025

AI's Role in Hip Reconstruction Devices Market

The integration of artificial intelligence (AI) in hip surgery is transforming patient care. AI assists in pre-surgical planning, intra-operative decision-making, and post-surgery rehabilitation. AI-powered systems are improving the precision of implant placements, enabling more accurate and faster procedures. This technology also helps in predicting potential complications, enhancing surgical outcomes and reducing recovery time for patients.

As AI continues to develop, its role in surgical planning, real-time feedback during surgery, and postoperative care will likely drive further improvements in the hip reconstruction devices market, allowing for greater adoption and expanding market opportunities.

🔗 What's Fueling the Next Wave of Growth? 👉 https://www.precedenceresearch.com/hip-reconstruction-devices-market

Hip Reconstruction Devices Market Key Growth Drivers

🔹 Aging Population: The increasing number of elderly individuals worldwide is driving demand for hip replacement surgeries.

🔹 Rising Incidence of Osteoarthritis: The prevalence of osteoarthritis is one of the primary contributors to the growing demand for joint replacement devices.

🔹 Technological Advancements: Innovations such as robotic-assisted surgery and AI tools for pre-surgery planning are making procedures more efficient and improving outcomes.

Hip Reconstruction Devices Market Opportunities

🔹 Material Advancements: The development of biocompatible materials and improved manufacturing technologies are creating new opportunities in implant design.

🔹 Growth in Emerging Markets: Increasing healthcare investments and infrastructure in regions like Asia Pacific provide significant growth prospects.

➡️ Become a valued research partner with us https://www.precedenceresearch.com/schedule-meeting

Hip Reconstruction Devices Market Trends

Key market trends include the growing adoption of robotics and navigation systems in hip replacement surgeries, improving precision and patient outcomes. Additionally, the demand for minimally invasive solutions is driving innovation in materials and surgical techniques, including advancements like 3D printing and customized implants. These trends are ensuring that the industry remains at the forefront of patient care.

🔓 Instant Access. Zero Waiting. 📥 Buy the Premium Market Research Report Now 👉 https://www.precedenceresearch.com/checkout/8331

Hip Reconstruction Devices Market Regional Analysis

North America led the market with a 40% share in 2025, driven by advanced healthcare systems, high adoption of robotic surgeries, and strong reimbursement frameworks. The U.S. remains the largest contributor due to a growing aging population, rising osteoarthritis cases, and rapid adoption of advanced surgical technologies.

Asia Pacific is the fastest-growing region, with a projected CAGR of 9%. Growth is supported by improving healthcare infrastructure, rising income levels, and increasing awareness of orthopedic treatments. China leads the region due to its large aging population and expanding healthcare access.

Europe held a 30% share in 2025 and is growing steadily due to increased adoption of minimally invasive and robotic surgeries, along with supportive reimbursement policies and aging demographics.

Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.

Try Before You Buy - Get the Sample Report@ https://www.precedenceresearch.com/sample/8331

Hip Reconstruction Devices Market Segment Analysis

🔸 Device Type Analysis

Hip arthroplasty (total hip replacement) led the market in 2025 with a 65% share. Its dominance is driven by its high success rate in treating advanced hip arthritis and improving patient quality of life. The procedure is widely recognized as cost-effective and reliable for managing end-stage osteoarthritis.

Hip revision surgery devices held a 10% share in 2025 and are expected to grow at the fastest CAGR of 7.5%. This growth is fueled by increasing cases of failed primary hip replacements and the rising elderly population, requiring more complex and specialized procedures.

Hip resurfacing devices accounted for 10% of the market and are gaining traction among younger, active patients due to their bone-preserving benefits. Partial hip replacement devices held an 8% share, supported by their use in selective fracture cases and advantages such as faster recovery and minimally invasive techniques.

🔸 Material Analysis

Metal-on-polyethylene (MoP) dominated with a 45% share in 2025 due to its durability, affordability, and strong clinical outcomes. It remains the most widely used material combination in hip implants.

Ceramic-on-ceramic (CoC) is projected to grow at the fastest CAGR of 8.5%, driven by its low wear rate, biocompatibility, and long-term durability, making it ideal for younger patients.

Metal-on-metal (MoM) accounted for 10% share, valued for lower dislocation risks in select cases. Ceramic-on-polyethylene (CoP), with a 25% share, is gaining popularity due to improved wear resistance and better outcomes in active elderly patients.

🔸 Surgery Type Analysis

Primary hip replacement surgery dominated the market with a 75% share in 2025. Its widespread use among elderly patients with arthritis and joint disorders drives its leading position.

Robotic-assisted hip surgery, though holding a 5% share, is expected to grow at the fastest CAGR of 15%. Its precision, accuracy, and improved surgical outcomes are accelerating adoption.

Hip revision surgeries held a 15% share and are growing steadily due to increasing complications in primary procedures. Minimally invasive surgeries, with a 5% share, are gaining popularity due to reduced recovery time, less scarring, and lower surgical risks.

🔸 End-Use Analysis

Hospitals dominated with a 65% share in 2025, supported by advanced infrastructure, skilled professionals, and the ability to perform complex surgeries with comprehensive post-operative care.

Ambulatory surgical centers (ASCs) held a 20% share and are growing due to cost-effective outpatient procedures and faster recovery times. Specialty orthopedic clinics, with a 15% share, are expanding rapidly due to personalized care and advanced treatment options.

Hip Reconstruction Devices Market Top Companies and Their Offerings

➢ Zimmer Biomet Holdings, Inc.: Zimmer Biomet offers a comprehensive portfolio of hip reconstruction products, addressing primary total hip arthroplasty, revision procedures, and patient‐matched solutions. Their range includes femoral stems, acetabular components, liners, and instrumentation, with focus on improved materials (e.g., porous metals) and surgical workflow enhancements for diverse patient anatomies.

➢ Stryker Corporation: Stryker provides hip replacement implants as part of its joint replacement suite, including primary and revision hip implant systems and associated instrumentation. Their portfolio supports a variety of implant styles and surgical approaches, including options designed to optimize fit and function.

➢ DePuy Synthes (Johnson & Johnson): DePuy Synthes (part of Johnson & Johnson MedTech) develops and markets hip reconstruction and total hip arthroplasty implants and instruments. Their solutions include clinically‐proven systems like ACTISTM Total Hip Solutions, C‐STEMTM femoral stems, and a range of acetabular solutions designed for both primary and revision cases, as well as enabling technologies for procedural efficiency.

➢ Smith & Nephew plc: Smith & Nephew's hip reconstruction offerings center around the POLAR3TM Total Hip Solution, which integrates the POLARSTEMTM Hip Reconstruction System, R3TM Acetabular System, and OXINIUMTM Technology bearings. These products are designed for excellent stability, bone ingrowth, and long‐term survivorship.

➢ Wright Medical Group N.V. (Acquired by Stryker):Wright Medical's hip reconstruction portfolio historically included hip arthroplasty systems (total, partial, revision) focused on biologic fixation and minimally invasive approaches. As part of Stryker, those products and technologies have been integrated into Stryker's broader hip replacement lineup over time.

➢ MicroPort Scientific Corporation: MicroPort Orthopedics offers total hip arthroplasty implants including acetabular systems and femoral stems in different design philosophies used in hip replacements. Their portfolio supports multiple surgical approaches with a long clinical history.

➢ B. Braun Melsungen AG: B. Braun delivers modular hip replacement systems emphasizing ease of use, modularity and comprehensive surgical support, often marketed under their Aesculap brand, with hip components for primary and revision procedures.

➢ Exactech, Inc.: Exactech is involved in hip reconstruction through implant systems and instrumentation with modular designs intended to enhance surgical efficiency and flexibility. Their product families include modular femoral stems and acetabular components aimed at simplifying implant logistics in the OR.

➢ DJO Global (part of Colfax Corporation): DJO Global's orthopedic reconstruction offerings include hip implant systems with cemented and cementless fixation options, emphasizing wear resistance and restoration of mobility. Their solutions are positioned for a range of patient profiles.

➢ Arthrex, Inc.: Arthrex's presence in the hip space is more support‐oriented, with soft‐tissue repair systems and anchors for hip procedures that complement reconstruction surgeries, but they are not a primary large joint hip implant manufacturer.

➢ Medtronic plc: Medtronic offers orthopedic implant solutions as part of its broader musculoskeletal portfolio, including devices used in joint reconstruction procedures, although its hip reconstruction portfolio is smaller compared to dedicated joint specialists.

➢ Corin Group: Corin develops hip replacement systems, including modular acetabular cups, femoral stems, and advanced bearing surfaces, complemented with digital planning tools and post‐operative analytics to optimize outcomes.

➢ Omni Life Science, Inc.: Omni Life Science operates in the hip reconstruction space by offering implant components tailored to joint replacement procedures, focusing on cost‐effective and reliable systems used in standard hip arthroplasty.

➢ Hapatec GmbH: Hapatec is a specialized provider that focuses on hip resurfacing and related hip reconstruction technologies, offering niche devices and minimally invasive solutions targeting specific surgical needs within hip arthroplasty.

➢ Cerapedics, Inc.: Cerapedics focuses on biodesign and biomaterial technologies that augment hip reconstruction procedures, including synthetic bone graft substitutes and biologic implants that support osseointegration and bone healing in hip surgeries.

Latest Breakthroughs

⚡ In March 2026, Maxx Orthopedics launched the Libertas KeystoneTM Hip System, offering a new approach to hip surgery with a short, metaphyseal fit-and-fill stem design. This new system is expected to streamline surgeries and improve patient recovery times.

⚡ In March 2026, ImpacTell, a French company, announced plans to commercialize its instrumented hammer designed to provide orthopedic surgeons with precise measurements of implant stability during hip replacement surgeries. Supported by the European Union, this technology promises to enhance surgical outcomes and implant longevity.

Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as North America, Europe, or Asia Pacific.

📥 Instant Report Delivery Available | 💳 Buy Now 👉 https://www.precedenceresearch.com/checkout/8331

Segments Covered in the Report

🔹 By Device Type

Hip Arthroplasty (Total Hip Replacement)
Hip Resurfacing Devices
Partial Hip Replacement Devices
Hip Revision Surgery Devices
Others (Impingement Devices, etc.)

🔹 By Material

Metal-on-Polyethylene (MoP)
Metal-on-Metal (MoM)
Ceramic-on-Polyethylene (CoP)
Ceramic-on-Ceramic (CoC)
Hybrid (Ceramic on Metal, etc.)

🔹 By Surgery Type

Primary Hip Replacement Surgery
Hip Revision Surgery
Minimally Invasive Hip Surgery
Robotic-assisted Hip Surgery

🔹 By End-Use

Hospitals
Ambulatory Surgical Centers (ASCs)
Specialty Orthopedic Clinics

🔹 By Region

North America
Latin America
Europe
Asia-pacific
Middle and East Africa

Connect With Us

📞 USA: +1 804 441 9344
📞 APAC: +61 485 981 310 or +91 87933 22019 | +6531051271
📞 Europe: +44 7383 092 044
📩 Email: sales@precedenceresearch.com

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

🌐 Web: https://www.precedenceresearch.com

Our Trusted Data Partners:
🔹https://www.towardshealthcare.com
🔹https://www.towardspackaging.com
🔹https://www.towardschemandmaterials.com
🔹https://www.towardsfnb.com
🔹https://www.marketstatsinsight.com

Get Recent News:
https://www.precedenceresearch.com/news

For the Latest Update, Follow Us:
🔹https://www.linkedin.com/company/precedence-research
🔹https://x.com/Precedence_R
🔹https://www.facebook.com/precedenceresearch
🔹https://precedence-research.medium.com/

This release was published on openPR.